dermalax deep plus

Here is a 310-word description of Dermalax Deep Plus:

Dermalax Deep Plus: High-Strength Hyaluronic Acid Filler for Deep Volumization & Structural Support

**Dermalax Deep Plus**, manufactured by **Luminera** (part of the Croma group), is a **highly cross-linked, high G-prime (G’) hyaluronic acid (HA) dermal filler** specifically engineered for **profound volumization and structural lifting** in areas requiring significant tissue support. It belongs to the premium segment of the Dermalax line, distinguished by its exceptional **density, cohesivity, and lifting capacity**.https://skin-reboot.com/

**Core Technology & Properties:**
* **High HA Concentration:** Contains a robust concentration of HA (typically 25 mg/mL), providing substantial intrinsic volumizing power.
* **Advanced Cross-Linking:** Utilizes Luminera’s proprietary **Advanced Hylacross Technology™** (or similar platform) to create a highly stable, three-dimensional HA network. This results in:
* **Very High Elastic Modulus (G’):** Provides strong tissue lifting force and resistance to deformation.
* **High Cohesivity:** Ensures the gel stays intact as a cohesive unit after injection, minimizing dispersion and maximizing localized support and projection.
* **Optimal Viscosity:** Balances injectability with tissue integration and longevity.
* **Optional PMMA Enhancement:** *Crucially, Dermalax Deep Plus is also available in formulations containing **Polymethylmethacrylate (PMMA) microspheres** (e.g., 20%) suspended within the HA gel.* These non-biodegradable microspheres provide a permanent scaffold for long-term collagen encapsulation, significantly extending the duration of effect beyond standard HA.

**Mechanism of Action:**
1. **Immediate Volumization & Lift:** The dense, cohesive HA gel provides instant filling and structural support upon injection into the deep dermis, subcutaneous tissue, or supraperiosteal plane.
2. **Hydration:** HA binds water, contributing to tissue hydration.
3. **Collagen Stimulation (HA Component):** HA naturally stimulates fibroblasts, promoting mild collagen production over time.
4. **Permanent Scaffolding (PMMA versions):** PMMA microspheres act as a permanent lattice, inducing sustained fibroblast activity and collagen deposition around them, leading to semi-permanent volumization. The HA carrier gel is gradually metabolized over 12-18 months.

**Primary Indications:**
* **Severe Midface/Cheek Volume Loss:** Restoring significant deflation and providing strong structural lift.
* **Deep Temporal Hollowing:** Correcting pronounced volume deficiency.
* **Jawline Contouring & Definition:** Enhancing mandibular projection and angle definition, countering jowling.
* **Chin Augmentation:** Adding substantial projection.
* **Pre-jowl Sulcus Correction.**
* **Nasolabial Folds (Severe):** When significant deep volume replacement is needed.

**Key Administration Considerations:**
* **Expert Injection Mandatory:** Requires injection **only by experienced physicians** proficient in deep facial anatomy and advanced volumization techniques.
* **Depth:** Must be injected **deep** (subcutaneous, supraperiosteal) to avoid visibility, palpability, or vascular compromise. Avoid superficial planes.
* **Technique:** Often delivered via **cannula** (e.g., 22-25G) or sturdy needle using **bolus, fanning, or linear threading** techniques. Requires significant injection force due to high viscosity.
* **PMMA Specifics:** *For PMMA-containing versions:* Requires meticulous technique to ensure even distribution. Higher risk of nodules/granulomas compared to pure HA. Permanent nature demands absolute precision and patient understanding.
* **Post-Treatment:** Expect significant swelling, bruising, and tenderness. Results mature over weeks as swelling subsides. PMMA collagen encapsulation takes months.
* **Longevity:** Pure HA version: 12-18+ months. *PMMA version: Semi-permanent (5+ years, potentially permanent).*
* **Potential Adverse Events:** Includes nodules (higher risk with PMMA), infection, hematoma, prolonged swelling, vascular compromise (critical to avoid with proper technique/depth), asymmetry, palpability. Delayed inflammatory reactions possible.
* **Regulatory Status:** Approved in various international markets (e.g., CE marked). *PMMA versions may have specific regulatory restrictions.*

Dermalax Deep Plus offers potent solutions for severe volume deficits and structural rejuvenation, with options ranging from high-performance HA to semi-permanent PMMA-enhanced volumization, demanding the highest level of injector expertise.CONTACT US